Radiofrequency (RF) uses high-frequency alternating electrical energy to generate controlled heating within periocular tissues.
As electrical energy passes through tissue, resistance to the current produces heat. In dry eye management, this controlled thermal effect is primarily used to warm the eyelids and meibomian glands, reduce meibum viscosity, and facilitate gland secretion and expression.
Unlike Quantum Molecular Resonance (QMR), which is designed to produce non-thermal electrical biological effects, radiofrequency intentionally generates heat as its principal therapeutic mechanism.
RF is therefore particularly relevant when gland obstruction and altered meibum flow are major components of meibomian gland dysfunction (MGD).
How radiofrequency works
The therapeutic effect of RF results from the conversion of electrical energy into controlled tissue heating.
Depending on the device, energy may be delivered through monopolar, bipolar, multipolar, or other dedicated RF configurations.
The resulting temperature increase may contribute to:
- softening and liquefaction of abnormal meibum;
- improvement of meibum flow;
- facilitation of subsequent gland expression;
- improvement of meibomian gland function;
- modulation of the periocular tissue environment.
Some RF systems also produce effects on dermal collagen and periocular tissue remodeling, but within Interventional Dry Eye the primary objective is functional treatment of obstructive MGD rather than cosmetic tissue remodeling.
Radiofrequency converts electrical energy into controlled heat to facilitate meibum flow and improve gland function.
RF is a thermal technology
This distinction is important within the WIDES therapeutic framework.
| Technology | Physical mechanism |
|---|---|
| Radiofrequency | Electrical EnergyTissue ResistanceControlled Heat |
| QMR | Low-Intensity Electrical FieldsNon-Thermal Biological Stimulation |
| JETT Silver Tip | Low-Intensity Electrical EnergyMembrane Polarization and Cellular Signaling |
Although these technologies all use electrical energy, their physical mechanisms and therapeutic objectives are fundamentally different.
They should therefore not be grouped together simply as "electrical treatments."
Why RF may be useful in MGD
Obstructive MGD is frequently associated with increasingly viscous or inspissated meibum.
When the glandular content becomes difficult to evacuate, warming the eyelids can decrease meibum viscosity and facilitate expression.
RF offers an in-office method of providing controlled and sustained periocular heating.
Clinical studies have reported improvements in:
- meibum quality;
- gland expressibility;
- tear break-up time;
- dry eye symptoms;
- corneal staining;
following RF-based treatment protocols, particularly when treatment is followed by meibomian gland expression.
Radiofrequency and meibomian gland expression
RF and meibomian gland expression are highly complementary.
RF first provides controlled thermal softening of the meibum, while expression subsequently evacuates retained glandular contents.
This sequence is particularly logical in patients with significant obstructive MGD:
Controlled HeatingReduced Meibum ViscosityGland ExpressionImproved Meibum Flow
A prospective multicenter cohort study of RF-assisted meibomian gland expression reported significant improvements in symptoms, TBUT, corneal fluorescein staining, and meibomian gland scores that persisted during follow-up.
Radiofrequency and IPL
Two complementary mechanisms
RF and IPL should not be considered competing technologies.
Their mechanisms are different and potentially complementary.
IPL
primarily targets:
- vascular abnormalities
- telangiectasia
- inflammation
- ocular rosacea
RF
primarily targets:
- controlled heating
- meibum viscosity
- gland obstruction
- meibum flow
This provides a strong rationale for combining the two technologies in selected patients presenting simultaneously with vascular/inflammatory MGD and significant gland obstruction.
A prospective study combining IPL + RF + meibomian gland expression reported substantial improvements in meibum quality and symptoms. The authors noted that the improvement in meibum quality was greater than in a historical cohort treated without RF, although randomized comparative studies were still required to isolate the specific contribution of RF.
Emerging evidence for combination therapy
Recent real-world comparative data further support the potential complementarity of RF and IPL.
A 2026 retrospective cohort including 286 patients with MGD-related DED compared RF alone, IPL alone, and combined RF + IPL treatment.
All three groups improved significantly, while the combined RF + IPL group showed the greatest improvement across several clinical outcomes, including symptoms and gland function. No serious adverse events were reported.
These findings are encouraging, but because this was a retrospective study, they should not be interpreted as definitive proof of superiority.
A randomized controlled trial specifically evaluating RF for MGD was also published in The Ocular Surface in 2026, illustrating the increasing scientific interest in this therapeutic modality.
Clinical indications
Within the WIDES Interventional Dry Eye approach, RF may be particularly considered in patients with:
Obstructive MGD
Patients with significant meibomian gland obstruction and reduced meibum flow.
Thick or inspissated meibum
Patients in whom gland expression reveals viscous, filamentous, or toothpaste-like secretions.
Poor gland expressibility
Patients whose meibomian glands require substantial pressure to evacuate retained secretion.
Evaporative DED
Patients in whom impaired lipid-layer function and MGD contribute significantly to tear-film instability.
MGD requiring combined IPL + RF treatment
Patients with both vascular/inflammatory disease and significant gland obstruction, particularly when ocular rosacea or lid-margin telangiectasia coexist with abnormal meibum.
The importance of gland structure
RF can improve the evacuation of meibum only when sufficient functional glandular tissue remains.
For this reason, treatment selection should take into account:
- meibography
- gland atrophy
- meibum quality
- gland expressibility
A patient with severe gland obstruction but relatively preserved glands may be an excellent candidate for a thermal and mechanical strategy.
Conversely, when advanced meibomian gland atrophy is present, the therapeutic objective must be reconsidered because heating cannot restore glands that have already been lost.
Meibography shows what remains.
Expression shows what still functions.
RF helps mobilize what can still be expressed.
Treatment protocol
RF protocols vary according to the device.
Important parameters include:
- energy delivery mode;
- target tissue temperature;
- treatment duration;
- number of passes;
- anatomical treatment area;
- number and frequency of sessions;
- association with gland expression or other technologies.
RF should therefore not be considered a single standardized treatment.
Treatment parameters must follow the specific device protocol and be adapted to the individual patient's clinical phenotype.
Several published protocols have used multiple sessions, often followed by meibomian gland expression. Combination protocols with IPL have also used repeated treatment sessions rather than a single procedure.
Safety
Periocular RF treatment requires controlled energy delivery and appropriate temperature monitoring.
Treatment should remain within the parameters specified for the device and anatomical area being treated.
Particular attention should be paid to:
- eyelid anatomy;
- ocular protection;
- treatment temperature;
- duration of energy delivery;
- patient comfort;
- skin and tissue response.
RF should be performed using devices and protocols appropriate for periocular or ophthalmic use.
Radiofrequency within the Interventional Dry Eye Concept
RF occupies a specific position within a multimodal therapeutic strategy.
A patient may simultaneously present with:
- telangiectasia
- inflammation
- gland obstruction
- thick meibum
- tear-film instability
- epithelial damage
Different technologies can therefore address different mechanisms.
| Technology | Component addressed |
|---|---|
| IPL | Vascular & inflammatory component |
| Radiofrequency | Thermal softening of meibum and facilitation of gland flow |
| Meibomian Gland Expression | Mechanical evacuation |
| QMR | Non-thermal electrical bio-stimulation and corneal epithelial involvement |
| PBM | Photochemical cellular modulation |
| JETT | Plasma or low-intensity electrical membrane modulation |
The objective is not to select a technology in isolation, but to combine complementary mechanisms according to the individual pathophysiological profile.
Why RF + IPL + MG expression makes sense
In selected patients with MGD, the combination can follow a logical therapeutic sequence:
- IPL addresses vascular and inflammatory abnormalities
- RF provides controlled heating and reduces meibum viscosity
- MG Expression evacuates the softened glandular content
This sequence illustrates the principle of therapeutic synergy at the heart of Interventional Dry Eye.
Inflammation + Obstruction require more than one mechanism of treatment.
Clinical take-home message
Radiofrequency is primarily a controlled thermal treatment for obstructive meibomian gland dysfunction.
By converting electrical energy into controlled tissue heating, RF can reduce meibum viscosity, facilitate gland expression, and improve the functional environment of the meibomian glands.
Its value is particularly evident when gland obstruction and altered meibum coexist with vascular or inflammatory disease, making RF highly complementary to IPL and meibomian gland expression.
RF should not be confused with QMR or other non-thermal electrical technologies: its principal therapeutic mechanism is controlled heat.
Within the WIDES Interventional Dry Eye Concept:
Accurate DiagnosisIdentification of ObstructionControlled RF HeatingGland ExpressionCombination with IPL When Inflammation or Vascular Disease Coexists